skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

New anticoagulant strategies in ST elevation myocardial infarction: Trials and clinical implications

Review

(2117) Views  (495) Full article downloads

Authors: Conor J McCann, Ian BA Menown

Published Date May 2008 Volume 2008:4(2) Pages 305 - 313
DOI: http://dx.doi.org/10.2147/VHRM.S1154

Conor J McCann, Ian BA Menown

Craigavon Cardiac Centre, Craigavon Area Hospital, Craigavon, Northern Ireland, UK

Abstract: New data have re-established the importance of anticoagulation of patients with ST segment elevation myocardial infarction (STEMI), both as an adjuvant to reperfusion therapy or in patients ineligible for reperfusion. Recent randomized trials have found newer agents to be superior to conventional unfractionated heparin. This article summarizes current understanding of the underlying pathophysiology of STEMI and provides a comprehensive review of emerging trial data for low molecular weight heparins, anti-factor Xa agents and direct thrombin inhibitors in this setting.

Keywords: myocardial infarction, treatment, anticoagulants








Readers of this article also read:

Tipifarnib in the treatment of acute myeloid leukemia
Risk factors for vascular dementia: Hypotension as a key point
Time-dependent alterations in serum NO concentration after oral administration of L-arginine, L-NAME, and allopurinol in intestinal ischemia/reperfusion
Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study
Preferred drug lists: Potential impact on healthcare economics
Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
Racial differences in diabetes-related psychosocial factors and glycemic control in patients with type 2 diabetes
Effects of ‘hoja de malvón’ disease on the composition, sensory properties and preference of Malbec wines from Mendoza, Argentina
Differential effects of amyloid-beta peptide aggregation status on in vivo retinal neurotoxicity
Measuring nutritional risk in hospitals
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University